Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changes of Inflammatory Cytokines in the Tears of Moderate and Severe MGD Treated With Topical Loteprednol Etabonate

NCT01692652 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT01692652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01692652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changes of Inflammatory Cytokines in the Tears of Moderate and Severe MGD Treated With Topical Loteprednol Etabonate
Lead sponsor
Yonsei University
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2012
Completion date
March 31, 2013
Enrollment
98 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

moderate and severe meibomiang gland dysfunction (stage 3 or stage 4 meibomiang gland dysfunction)